vs
COGENT COMMUNICATIONS HOLDINGS, INC.（CCOI）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
COGENT COMMUNICATIONS HOLDINGS, INC.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.2倍（$240.5M vs $207.3M），COGENT COMMUNICATIONS HOLDINGS, INC.净利率更高（-12.8% vs -62.0%，领先49.2%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -4.7%），COGENT COMMUNICATIONS HOLDINGS, INC.自由现金流更多（$-43.0M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -4.9%）
高智通信控股公司是总部设在美国的跨国互联网服务供应商，核心业务包括光纤IP专用网络下的互联网接入与数据传输服务，同时也提供数据中心服务器托管业务，在全球互联网基础设施领域拥有广泛的业务布局。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
CCOI vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $240.5M | $207.3M |
| 净利润 | $-30.8M | $-128.6M |
| 毛利率 | 46.6% | — |
| 营业利润率 | -4.7% | -54.7% |
| 净利率 | -12.8% | -62.0% |
| 营收同比 | -4.7% | 25.9% |
| 净利润同比 | 28.9% | 3.5% |
| 每股收益（稀释后） | $-0.63 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $240.5M | $207.3M | ||
| Q3 25 | $241.9M | $159.9M | ||
| Q2 25 | $246.2M | $166.5M | ||
| Q1 25 | $247.0M | $139.3M | ||
| Q4 24 | $252.3M | $164.6M | ||
| Q3 24 | $257.2M | $139.5M | ||
| Q2 24 | $260.4M | $147.0M | ||
| Q1 24 | $266.2M | $108.8M |
| Q4 25 | $-30.8M | $-128.6M | ||
| Q3 25 | $-41.5M | $-180.4M | ||
| Q2 25 | $-57.8M | $-115.0M | ||
| Q1 25 | $-52.0M | $-151.1M | ||
| Q4 24 | $-43.3M | $-133.2M | ||
| Q3 24 | $-63.1M | $-133.5M | ||
| Q2 24 | $-32.3M | $-131.6M | ||
| Q1 24 | $-65.3M | $-170.7M |
| Q4 25 | 46.6% | — | ||
| Q3 25 | 45.6% | — | ||
| Q2 25 | 44.2% | — | ||
| Q1 25 | 44.4% | — | ||
| Q4 24 | 38.5% | — | ||
| Q3 24 | 37.2% | — | ||
| Q2 24 | 40.0% | — | ||
| Q1 24 | 36.5% | — |
| Q4 25 | -4.7% | -54.7% | ||
| Q3 25 | -7.5% | -106.9% | ||
| Q2 25 | -12.8% | -64.8% | ||
| Q1 25 | -16.3% | -102.6% | ||
| Q4 24 | -13.2% | -74.3% | ||
| Q3 24 | -22.5% | -94.6% | ||
| Q2 24 | -18.1% | -79.1% | ||
| Q1 24 | -22.3% | -151.9% |
| Q4 25 | -12.8% | -62.0% | ||
| Q3 25 | -17.2% | -112.8% | ||
| Q2 25 | -23.5% | -69.0% | ||
| Q1 25 | -21.1% | -108.5% | ||
| Q4 24 | -17.2% | -80.9% | ||
| Q3 24 | -24.5% | -95.7% | ||
| Q2 24 | -12.4% | -89.5% | ||
| Q1 24 | -24.5% | -156.8% |
| Q4 25 | $-0.63 | $-1.28 | ||
| Q3 25 | $-0.87 | $-1.81 | ||
| Q2 25 | $-1.21 | $-1.17 | ||
| Q1 25 | $-1.09 | $-1.57 | ||
| Q4 24 | $-0.89 | $-1.34 | ||
| Q3 24 | $-1.33 | $-1.40 | ||
| Q2 24 | $-0.68 | $-1.52 | ||
| Q1 24 | $-1.38 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $148.5M | $421.0M |
| 总债务越低越好 | $1.7B | — |
| 股东权益账面价值 | $-63.8M | $-80.0M |
| 总资产 | $3.1B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $148.5M | $421.0M | ||
| Q3 25 | $147.1M | $202.5M | ||
| Q2 25 | $213.7M | $176.3M | ||
| Q1 25 | $153.8M | $127.1M | ||
| Q4 24 | $198.5M | $174.0M | ||
| Q3 24 | $279.2M | $150.6M | ||
| Q2 24 | $384.4M | $480.7M | ||
| Q1 24 | $118.4M | $112.3M |
| Q4 25 | $1.7B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-63.8M | $-80.0M | ||
| Q3 25 | $-39.2M | $9.2M | ||
| Q2 25 | $46.7M | $151.3M | ||
| Q1 25 | $142.8M | $144.2M | ||
| Q4 24 | $222.8M | $255.0M | ||
| Q3 24 | $323.6M | $346.8M | ||
| Q2 24 | $415.5M | $432.4M | ||
| Q1 24 | $500.6M | $140.3M |
| Q4 25 | $3.1B | $1.5B | ||
| Q3 25 | $3.1B | $1.2B | ||
| Q2 25 | $3.3B | $1.3B | ||
| Q1 25 | $3.1B | $1.3B | ||
| Q4 24 | $3.2B | $1.5B | ||
| Q3 24 | $3.2B | $1.5B | ||
| Q2 24 | $3.3B | $1.6B | ||
| Q1 24 | $3.1B | $1.3B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.53× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.0M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-43.0M | $-100.8M |
| 自由现金流率自由现金流/营收 | -17.9% | -48.6% |
| 资本支出强度资本支出/营收 | 15.4% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-198.1M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $-6.0M | $-99.8M | ||
| Q3 25 | $3.1M | $-91.4M | ||
| Q2 25 | $-44.0M | $-108.3M | ||
| Q1 25 | $36.4M | $-166.5M | ||
| Q4 24 | $14.5M | $-79.3M | ||
| Q3 24 | $-20.2M | $-67.0M | ||
| Q2 24 | $-22.2M | $-77.0M | ||
| Q1 24 | $19.2M | $-190.7M |
| Q4 25 | $-43.0M | $-100.8M | ||
| Q3 25 | $-33.1M | $-92.7M | ||
| Q2 25 | $-100.2M | $-110.7M | ||
| Q1 25 | $-21.7M | $-167.8M | ||
| Q4 24 | $-31.6M | $-79.5M | ||
| Q3 24 | $-79.5M | $-68.6M | ||
| Q2 24 | $-70.9M | $-79.0M | ||
| Q1 24 | $-21.7M | $-193.9M |
| Q4 25 | -17.9% | -48.6% | ||
| Q3 25 | -13.7% | -58.0% | ||
| Q2 25 | -40.7% | -66.5% | ||
| Q1 25 | -8.8% | -120.5% | ||
| Q4 24 | -12.5% | -48.3% | ||
| Q3 24 | -30.9% | -49.2% | ||
| Q2 24 | -27.2% | -53.7% | ||
| Q1 24 | -8.1% | -178.2% |
| Q4 25 | 15.4% | 0.5% | ||
| Q3 25 | 15.0% | 0.8% | ||
| Q2 25 | 22.8% | 1.5% | ||
| Q1 25 | 23.5% | 1.0% | ||
| Q4 24 | 18.3% | 0.1% | ||
| Q3 24 | 23.0% | 1.2% | ||
| Q2 24 | 18.7% | 1.4% | ||
| Q1 24 | 15.4% | 3.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCOI
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
